Navigation Links
Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care

including several European countries and the USA. The compound is not currently approved in the United States.

The most common adverse events reported in ACTEMRA(TM) global clinical studies are upper respiratory tract infections, headache, nasopharyngitis and hypertension. As with other biological disease modifying anti-rheumatic drugs (DMARDs), serious infections have been reported in some patients treated with ACTEMRA(TM).

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2006, Roche was named one of the Top 20 Employers (Science magazine), ranked the No. 1 Company to Sell For (Selling Power), and one of AARP's Top Companies for Older Workers, and in 2005, Roche was named one of Fortune magazine's Best Companies to Work For in America. For additional information about the U.S. pharmaceuticals business, visit our websites: http://www.rocheusa.com or www.roche.us.

    (1) ACR20, ACR50 and ACR70 represent the percentage of reduction (20%, 50%

        or 70%) in certain RA symptoms and measures the number of tender

        and swollen joints, pain, patient's and physician's global assessments

        and certain laboratory markers. An ACR70 response is considered

        exceptional and represents a significant improvement in a patient's

        condition.

    (2) The Disease Activity Score (DAS)28 is a combined index that measures

        disease activity in patients with RA. It combin
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
2. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
3. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
6. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
7. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
8. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
9. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
10. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
11. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
Post Your Comments:
(Date:9/30/2014)... Sept. 30, 2014 In 2011, approximately 5.1 ... abused prescription pain relievers (e.g. opioids). 1 ... treatment, which entails the use of buprenorphine, buprenorphine/naloxone, naltrexone ... are important when developing and improving care management programs, ... manager Prime Therapeutics LLC (Prime). ...
(Date:9/30/2014)... , Sept. 30, 2014 Organovo Holdings, ... company focused on delivering breakthrough 3D bioprinting technology, ... been selected as a finalist in the Diagnostics ... Innovative New Product Awards, sponsored by CONNECT. CONNECT, a ... technology and life sciences products in ...
(Date:9/30/2014)... September 30, 2014 , ... feature in-store events will change the way retail pharmaceutical ... the way we use and view pharmacies, Health First ... By catering to the very trendy public demands of ... of in-store events with various activities for both children ...
Breaking Medicine Technology:Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3Health First Pharmacy Redefines 'Pharmacy Retail Experience' 2Health First Pharmacy Redefines 'Pharmacy Retail Experience' 3
... SAN RAMON, Calif., Nov. 29, 2011 Odyssey ... biologically-relevant pathways in human cells, announced today that ... a laser-based confocal imaging platform from GE Healthcare, ... Odyssey Thera applies a systems ...
... Nov. 29, 2011 A new study in The ... a novel mechanism that cancer cells may use to escape ... cells induce tumor cell resistance to cytotoxic T cells in ... Center in Tampa, Fla., shows that a specific type of ...
Cached Medicine Technology:Odyssey Thera is First to Install Next Generation High-Content Imaging Capability 2New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 2New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 3
(Date:9/30/2014)... the University of Michigan have described a new approach ... of the time needed for more traditional methods. ... antibody that is undergoing further investigation as a potential ... , In research published online in the ... in the lab of Stephen Weiss at the U-M ...
(Date:9/30/2014)... 30, 2014 The St. Louis Physician ... Physician Group, comprised of more than 500 physicians, has ... of initiatives. With the recent addition of SLUCare, ... its market footprint to better respond to the changing ... SLPA is a physician-led clinically integrated network (CIN) of ...
(Date:9/30/2014)... Lea Blackwell, M.D., a Breast Surgeon at ... new, more practical and comfortable option for a bra ... and lumpectomy surgeries use special bras after surgery to ... patients describe the bra as scratchy, uncomfortable and restrictive, ... in her spare time. , Ilona Martin was ...
(Date:9/30/2014)... AxoGen, Inc. (NASDAQ: AXGN), ... nerve repair market, announced the presentation of clinical data ... for Surgery of the Hand (ASSH) 2014 Annual Meeting ... , The ASSH Best Paper Award was given ... Allografts for Large Gap Nerve Discontinuities: Outcomes From a ...
(Date:9/30/2014)... Brig Hart, one of the most successful ... Diamond-ranked professionals using his systematic way of building a ... Life Support System for Ultimate Success , founded on ... his experiences and successes over the past 30 years, ... methodology taught by Brig in this system, Mick and ...
Breaking Medicine News(10 mins):Health News:New discovery approach accelerates identification of potential cancer treatments 2Health News:St. Louis Physician Alliance Expands Network and Market Footprint with Recent Addition of SLUCare Physician Group 2Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 2Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 2Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 4Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 5Health News:Brig Hart Announces the First Diamond Elite Representatives using his Life Support System 2Health News:Brig Hart Announces the First Diamond Elite Representatives using his Life Support System 3
... way deter the elders from chatting or surfing the Internet ... net on par// with the youngsters. ,The survey conducted ... Marketing Services has revealed that senior netizens are a fast-growing ... million by 2008. ,These seniors - who number ...
... very common in North America with an estimated 400,000 people ... these //people have their hearts pumping again and only 6 ... causes of death after the heart is restarted is brain ... Society for Academic Emergency Medicine Annual Meeting, May 18-21, in ...
... get themselves screened for HIV, city-run medical clinics have relaxed ... the new rule, counseling sessions and written informed consent is ... is a verbal consent from the patient. ,This ... relaxed with respect to consent and counseling. Two hospitals and ...
... have issued a warning to drug users about the quality ... is being sold on the west coast// of Scotland has ... the beginning of this year there has been 82 inquiries ... same period last year. The police have said that not ...
... say may fight two dangerous germs that bedevil hospitals//. ... Laboratories and his colleagues looked at 250,000 extracts from ... from around the world, the health portal HealthDay News ... African soil, which they say could fight staph an ...
... Following high incidence of a potentially dangerous infection associated ... Bausch & Lomb//, those in Hong Kong, US and ... controversial product has been withdrawn from sales. ... product. However the company has been unable to claim ...
Cached Medicine News:Health News:Elders Too Are Keen To Chat On Internet On Par With Youngsters 2Health News:Survival After Cardiac Arrest Is Aided By Cooling 2
... in the field of hammertoe implants with the ... grade silicone, these durable and lasting implants will ... flexibility while maintaining correct toe length and shape. ... Lengths are determined by the surgeon for each ...
... Implant (KGTI) system offers the latest technology ... MPJ. The implant system is anatomically designed ... ,The KGTI is the most advanced reconstructive ... on the market today. The system consists ...
... has been approved for use as an ... seizures in adults and adolescents over 12 ... that are refractory to antiepileptic medications. This ... controlled, clinical trials. Efficacy, measured as median ...
Ad-Techs Spinal Electrodes are intended for intraoperative monitoring of Evoked Potentials (EPs) of the descending pathway during spinal surgery. They are offered with 2 or 3 platinum contacts....
Medicine Products: